Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tansy Edwards

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
The New England Journal of Medicine|January 7, 2016
Evaluation of Convalescent Plasma for Ebola Virus Disease in GuineaJohan van Griensven, Tansy Edwards, Xavier de Lamballerie, et al.
Vaccines|August 29, 2024
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the CongoEdward Man-Lik Choi, Kambale Kasonia, Hugo Kavunga-Membo, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Plos Neglected Tropical Diseases|June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trialAhmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Plos Neglected Tropical Diseases|November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trialAsrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Vaccines|August 29, 2024
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the CongoHugo Kavunga-Membo, Deborah Watson-Jones, Kambale Kasonia, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The New England Journal of Medicine|January 7, 2016
Evaluation of Convalescent Plasma for Ebola Virus Disease in GuineaJohan van Griensven, Tansy Edwards, Xavier de Lamballerie, et al.
Vaccines|August 29, 2024
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the CongoEdward Man-Lik Choi, Kambale Kasonia, Hugo Kavunga-Membo, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Plos Neglected Tropical Diseases|June 23, 2012
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trialAhmed Musa, Eltahir Khalil, Asrat Hailu, et al.
Plos Neglected Tropical Diseases|November 5, 2010
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trialAsrat Hailu, Ahmed Musa, Monique Wasunna, et al.
Vaccines|August 29, 2024
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the CongoHugo Kavunga-Membo, Deborah Watson-Jones, Kambale Kasonia, et al.
Pageof 9